Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, but the company stopped just short of saying it will definitely pull the drug from the market. The… read on > read on >
Kids struggling with mental health problems have a tougher time recovering from a concussion, a new study finds. These troubled kids tend to have more emotional symptoms after concussion and take longer to fully recover, results show. In fact, the more mental health diagnoses a child had, the worse their emotional symptoms and the longer… read on > read on >
Days clogged with numerous after-school activities are detrimental to the mental health of over-scheduled high school students, a new study finds. Researchers also found that these “enrichment’ activities — tutoring, sports, school clubs and even homework — are unlikely to benefit students academically. Many folks think extra study time or tutoring will lead to better… read on > read on >
Real-world data show that a shot that protects babies against RSV is 90% effective in keeping them out of the hospital. Those numbers outstrip what had been expected of Beyfortus (nirsevimab), which in clinical trials had prevented the need for medical care for RSV infection by 79% and hospitalization by 81%, researchers from the U.S.… read on > read on >
Endometriosis causes crippling pain in women, with some spending up to a month of every year debilitated by it. “We’re talking about pain that’s beyond ‘I took two ibuprofen and went to work,’” said Dr. Kristin Riley, chief of minimally invasive gynecologic surgery at Penn State Health Medical Center. “We’re talking about pain that keeps… read on > read on >
Wegovy (semaglutide), the weight-loss version of blockbuster diabetes drug Ozempic, was approved on Friday by the U.S. Food and Drug Administration to help prevent heart attack, stroke and heart death. “Wegovy is now the first weight-loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity… read on > read on >
Instead of approving the new Alzheimer’s drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the drug’s maker said Friday. “The FDA has informed Lilly it wants to further understand topics related to evaluating the safety and… read on > read on >
More Americans exposed to radiation caused by the government would be compensated under a bill that passed the U.S. Senate Thursday. The bipartisan legislation, which would cost an estimated $50 billion, would expand the Radiation Exposure Compensation Act (RECA) to include more people who believe that radiation exposure caused illnesses such as cancer. The bill… read on > read on >
Lots of seniors are regularly taking low-dose aspirin in hopes of preventing heart attacks and strokes, even though updated guidelines often advise against it. About one in four older adults take aspirin at least three times a week, according to results from the University of Michigan’s National Poll on Health Aging. However, many seniors who… read on > read on >
Folks worried about becoming flabby in middle age should check out what their parents looked like when they were that age, a new study says. People are six times more likely to become obese in middle age if both their parents were chubby during that time of their lives, according to research to be presented… read on > read on >
